We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Noninvasive Fat Removal Technologies Offer Alternative to Liposuction

By HospiMedica International staff writers
Posted on 21 Feb 2012
Noninvasive fat removal technologies such as radiofrequency (RF), cryolipolysis, and ultrasound are emerging as viable treatment options for people who are not appropriate candidates for liposuction. More...


One of the newest fat reduction technologies is RF, which delivers energy to fat deposits by driving controlled heat deep within the fat cells and destroying them. While RF has not yet been approved by the US Food and Drug Administration (FDA) for fat removal, the technology is being widely used by dermatologists with much success for people with pockets of excess fat. Since there is no downtime with this procedure, patients can resume their regular activities immediately. Another benefit of RF is its ability to both reduce fat and tighten the skin by directing energy to targeted collagen tissues.

A new, noninvasive procedure that is approved by the FDA is cryolipolysis, which is being used to remove localized areas of fat in the lower abdomen or along the sides of the body. Since fat cells are more sensitive to cold temperatures than other skin cells, cryolipolysis freezes the lipids in fat cells, which then slowly dissolve with no trauma or injury to surrounding tissues. For this reason, results are not immediate and fat layer reduction becomes visible gradually over the course of two to six months. Currently, cryolipolysis only allows for the treatment of larger areas of fat, but future developments could enable dermatologists to treat the inner thighs, neck, and arms for more refined fat reduction.

A third technique under investigation is using high-intensity, focused ultrasound waves to cause destruction and leakage of fat cells. Similar to the other noninvasive procedures used for fat reduction, the ultrasound energy penetrates through the skin layers into the targeted fat without harming skin or surrounding tissues. The difference is that ultrasound involves the mechanical destruction of the fat cells which then dissolve gradually over time, rather than destruction by temperature extremes.

“Fat cells are by nature very different than other cells, particularly in how they respond to stimuli such as temperature,” said dermatologist Lisa Donofrio, MD, of the department of dermatology at Yale University School of Medicine (New Haven, CT, USA). “Most of the new technologies recently introduced for fat removal were developed based on this knowledge and, as a result, can target specific areas of body fat using energy delivered as either heat or cold.”

The noninvasive procedures are not meant to replace tumescent liposuction for fat removal, a controlled, precise procedure that differs from the novel “wait-and-see” external fat reduction approaches, and the candidates are not in the same class either. For example, patients who are taking blood thinners or have a contraindication for surgical procedures are not good candidates for tumescent liposuction, but could be candidates for a noninvasive procedure.

Related Links:

Yale University School of Medicine



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.